TTM
$3.11
YoY change
-51.3%
5Y CAGR
+8.3%
Peak year (FY2024)
$7.64
Latest annual
$3.72
EPS (Diluted) history chart for Abbott Laboratories (ABT) from 2016 to 2025
Latest: $3.72
EPS (Diluted) growth chart for Abbott Laboratories (ABT) from 2016 to 2025
Latest: -51.3%
EPS (Diluted) history table for Abbott Laboratories (ABT) from 1985 to 2025
| FY2025 | $3.72 | -51.3% | -$3.92 | ||
| FY2024 | $7.64 | +133.6% | +$4.37 | ||
| FY2023 | $3.27 | -16.4% | -$0.64 | ||
| FY2022 | $3.91 | -0.8% | -$0.03 | ||
| FY2021 | $3.94 | +57.6% | +$1.44 | ||
| FY2020 | $2.50 | +21.4% | +$0.44 | ||
| FY2019 | $2.06 | +53.7% | +$0.72 | ||
| FY2018 | $1.34 | +396.3% | +$1.07 | ||
| FY2017 | $0.27 | -71.3% | -$0.67 | ||
| FY2016 | $0.94 | -68.0% | -$2.00 | ||
| FY2015 | $2.94 | +96.0% | +$1.44 | ||
| FY2014 | $1.50 | -8.5% | -$0.14 | ||
| FY2013 | $1.64 | -56.3% | -$2.11 | ||
| FY2012 | $3.75 | +24.6% | +$0.74 | ||
| FY2011 | $3.01 | +1.3% | +$0.04 | ||
| FY2010 | $2.97 | -19.7% | -$0.73 | ||
| FY2009 | $3.70 | +18.2% | +$0.57 | ||
| FY2008 | $3.13 | +35.5% | +$0.82 | ||
| FY2007 | $2.31 | +106.2% | +$1.19 | ||
| FY2006 | $1.12 | -48.1% | -$1.04 | ||
| FY2005 | $2.16 | +4.9% | +$0.10 | ||
| FY2004 | $2.06 | +17.7% | +$0.31 | ||
| FY2003 | $1.75 | -1.7% | -$0.03 | ||
| FY2002 | $1.78 | +79.8% | +$0.79 | ||
| FY2001 | $0.99 | -44.4% | -$0.79 | ||
| FY2000 | $1.78 | +13.4% | +$0.21 | ||
| FY1999 | $1.57 | +5.4% | +$0.08 | ||
| FY1998 | $1.49 | +12.0% | +$0.16 | ||
| FY1997 | $1.33 | +11.8% | +$0.14 | ||
| FY1996 | $1.19 | +12.3% | +$0.13 | ||
| FY1995 | $1.06 | +14.0% | +$0.13 | ||
| FY1994 | $0.93 | +10.7% | +$0.09 | ||
| FY1993 | $0.84 | +13.5% | +$0.10 | ||
| FY1992 | $0.74 | +15.6% | +$0.10 | ||
| FY1991 | $0.64 | +14.3% | +$0.08 | ||
| FY1990 | $0.56 | +14.3% | +$0.07 | ||
| FY1989 | $0.49 | +16.7% | +$0.07 | ||
| FY1988 | $0.42 | +20.0% | +$0.07 | ||
| FY1987 | $0.35 | +20.7% | +$0.06 | ||
| FY1986 | $0.29 | +16.0% | +$0.04 | ||
| FY1985 | $0.25 | — | — |
- FY2025$3.72-51.3%
- FY2024$7.64+133.6%
- FY2023$3.27-16.4%
- FY2022$3.91-0.8%
- FY2021$3.94+57.6%
- FY2020$2.50+21.4%
- FY2019$2.06+53.7%
- FY2018$1.34+396.3%
- FY2017$0.27-71.3%
- FY2016$0.94-68.0%
- FY2015$2.94+96.0%
- FY2014$1.50-8.5%
- FY2013$1.64-56.3%
- FY2012$3.75+24.6%
- FY2011$3.01+1.3%
- FY2010$2.97-19.7%
- FY2009$3.70+18.2%
- FY2008$3.13+35.5%
- FY2007$2.31+106.2%
- FY2006$1.12-48.1%
- FY2005$2.16+4.9%
- FY2004$2.06+17.7%
- FY2003$1.75-1.7%
- FY2002$1.78+79.8%
- FY2001$0.99-44.4%
- FY2000$1.78+13.4%
- FY1999$1.57+5.4%
- FY1998$1.49+12.0%
- FY1997$1.33+11.8%
- FY1996$1.19+12.3%
- FY1995$1.06+14.0%
- FY1994$0.93+10.7%
- FY1993$0.84+13.5%
- FY1992$0.74+15.6%
- FY1991$0.64+14.3%
- FY1990$0.56+14.3%
- FY1989$0.49+16.7%
- FY1988$0.42+20.0%
- FY1987$0.35+20.7%
- FY1986$0.29+16.0%
- FY1985$0.25—
EPS (Diluted) values are taken from Abbott Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EPS (Diluted) at Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current diluted EPS (TTM) is $3.11. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Abbott Laboratories (ABT) diluted EPS totalled $3.72 – plunged 51.3% year-over-year.
Across 2020–2025 (5 years), Abbott Laboratories diluted EPS produced a CAGR of +8.3% – with mixed annual results across the window.
Abbott Laboratories diluted EPS plunged from $7.64 in 2024 to $3.72 in 2025, a 51.3% drawdown.
The record annual diluted EPS stands at $7.64, reached in 2024; the historical low of $0.25 was recorded in 1985.
Abbott Laboratories EPS (Diluted) by Year
Abbott Laboratories EPS (Diluted) 2025: $3.72
Abbott Laboratories posted diluted EPS of $3.72 in 2025, plunged 51.3% below 2024.
Abbott Laboratories EPS (Diluted) 2024: $7.64
In 2024, Abbott Laboratories reported diluted EPS of $7.64, surged 133.6% from 2023. This figure represents the highest annual value in the available history.
Abbott Laboratories EPS (Diluted) 2023: $3.27
Abbott Laboratories diluted EPS in 2023 was $3.27, declined 16.4% below 2022.
Abbott Laboratories EPS (Diluted) 2022: $3.91
2022's diluted EPS for Abbott Laboratories came in at $3.91, edged down 0.8% below 2021.
Abbott Laboratories EPS (Diluted) 2021: $3.94
Abbott Laboratories diluted EPS in 2021 was $3.94.
See more financial history for Abbott Laboratories (ABT). Or calculate EPS yourself.
Sector peers by EPS (Diluted)
Healthcare peers of Abbott Laboratories (ABT), ranked by their latest diluted EPS
| $22.95 | |
| $17.74 | |
| $14.23 | |
| $13.23 | |
| $11.03 | |
| $7.28 | |
| $6.54 | |
| $2.37 |
- $22.95
- $14.23
- $13.23
- $11.03
- $7.28
- $6.54
- $2.37
Frequently asked questions
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.16% TTM
- Dividend Profile2.30% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History9 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.